Industry News: Bristol-Myers Squibb, GE, TeraMedica and eCARE

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Bristol-Myers Squibb Medical Imaging has been granted permission by the European Commission for marketing of LUMINITY, an ultrasound contrast agent, for use in patients with suboptimal echocardiograms who have suspected or established coronary artery disease. Echocardiography with contrast enhancement is recommended by the British and American Societies of Echocardiography as a method of improving the diagnostic accuracy of suboptimal echocardiograms. LUMINITY helps clinicians gather images of the left ventricular chamber and improve the delineation of the left endocardial border during both rest and stress echocardiography. In a recent study of stress echocardiography, where the resting images were difficult to interpret, 95 percent of the LUMINITY-enhanced images were diagnostic compared to 66 percent of the unenhanced images, and use of the agent reduced the need for follow-up tests, the company says.


GE Healthcare topped the ranks in MD Buyline’s 3rd Quarter 2006 survey for radiology system performance, installation and implementation services, and service response time. The rankings show that GE’s score has improved over the previous quarter in five of the six categories.


TeraMedica Healthcare Technology announced a joint marketing agreement with eCARE Solutions, a personal health record (PHR) provider, for an image-enabled personal health record. TeraMedica's Evercore integrated with the eCare Personal Health Desktop comprises a system that enables physicians and patients to access instantly medical images such as x-rays and MRI scans or cardiology exams, as well as other types of clinical digital content such as electronic reports, from a patient's existing PHR desktop.